Reciprocal interactions between α2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat A. HärfstrandK. FuxeB. Fredholm Original Papers Pages: 83 - 99
Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment E. WiderlövR. EkmanK. Nyman Original Papers Pages: 101 - 109
The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls K. -P. LeschE. WiderlövH. Beckmann Original Papers Pages: 111 - 118
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease J. SirviöR. KutvonenP. J. Riekkinen Original Papers Pages: 119 - 127
The ratio of acetylcholinesterase to butyrylcholinesterase influences the specificity of assays for each enzyme in human brain F. J. HuffC. T. ReiterJ. B. Rand Original Papers Pages: 129 - 134
Postmortem- and cryostability of the potassium-evoked release of [3H]5-hydroxytryptamine from rat cerebral cortical miniprisms C. J. FowlerG. ThorellI. Fagervall Original Papers Pages: 135 - 148
Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPA T. BrannanP. KnottM. Yahr Original Papers Pages: 149 - 157
Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine J. D. Fernstrom Short Note Pages: 159 - 164